PE anti-human CD90 (Thy1) Antibody

Pricing & Availability
5E10 (See other available formats)
Regulatory Status
HCDM listed
Other Names
Thy-1, Thy1
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
Human erythroleukemic cell line HEL stained with 5E10 PE
  • 5E10_PE_021508
    Human erythroleukemic cell line HEL stained with 5E10 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
328109 25 tests 108€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
328110 100 tests 234€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

CD90 is a 25-35 kD GPI-anchored protein, also known as Thy-1. It belongs to the Ig superfamily. Human CD90 is expressed on neuronal cells, a subset of CD34+ cells, a subset of fetal liver cells and fetal thymocytes, fibroblasts, activated endothelial cells, and some leukemia cell lines. CD34+CD90+ cells are primitive hematopoietic stem cells. It has been reported that Thy-1 binds with β2 and β3 integrins and plays bimodal roles in the regulation of cell adhesion and neurite outgrowth, and inhibits hematopoietic stem cells proliferation and differentiation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Reported Reactivity
African Green, Baboon, Cynomolgus, Pigtailed Macaque, Rhesus, Pig
Antibody Type
Host Species
HEL cells
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4 Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.

Application References

(PubMed link indicates BioLegend citation)
  1. Craig W, et al. 1993. J. Exp. Med. 177:1331. (IP)
  2. Gundlach CW 4th, et al. 2011. Bioconjug. Chem. 22:1706. (Pig Reactivity)
  3. Touboul C, et al. 2013. J. Transl. Med. 11:28. (IF)
  4. Bradley JE, et al. 2013. Lab Invest. 93:365. (Epitope)
  5. Donnenberg VS, et al. 2010. Cytometry B. Clin. Cytom. 5:287. (IHC)
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
  3. Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
  4. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  5. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  6. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  7. Ye T, et al. 2023. Bioact Mater. 21:194. PubMed
  8. Liu C, et al. 2022. BMC Oral Health. 22:536. PubMed
  9. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  10. Tevlin R, et al. 2023. Sci Rep. 13:2097. PubMed
  11. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  12. Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
  13. Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
  14. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  15. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  16. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  17. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  18. Park J, et al. 2022. Bone Joint Res. 11:777. PubMed
  19. Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
  20. Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
  21. Yang J, et al. 2022. Cell Discov. 8:92. PubMed
  22. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  23. Branco MA, et al. 2020. Methods Mol Biol. . PubMed
  24. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  25. Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
  26. Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
  27. Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
  28. Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
  29. Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
  30. Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
  31. Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
  32. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  33. Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
  34. Santos J, et al. 2013. J Transl Med. 11:18. PubMed
  35. Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
  36. Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
  37. Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
  38. Ye W, et al. 2022. Regen Ther. 21:477. PubMed
  39. Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
  40. Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
  41. Alexander TB, et al. 2018. Nature. 562:373. PubMed
  42. Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
  43. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  44. Morris K, et al. 2014. PLoS One. 9:98656. PubMed
  45. Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
  46. Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
  47. Lee JK, et al. 2021. Cells. 10:. PubMed
  48. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  49. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  50. Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
  51. Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
  52. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  53. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  54. Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
  55. Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
  56. Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
  57. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  58. Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
  59. Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
  60. Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
  61. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  62. Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
  63. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  64. Bailey AL, et al. 2020. bioRxiv. . PubMed
  65. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
AB_893442 (BioLegend Cat. No. 328109)
AB_893433 (BioLegend Cat. No. 328110)

Antigen Details

25-35 kD glycoprotein, Ig superfamily

Subset of CD34+ hematopoietic stem cells, subset of fetal thymocytes, subset of fetal liver cells, fibroblast, activated endothelial cells, neurons and some leukemia cell lines

Regulate hematopoiesis and neural cell growth, cell adhesion
β3 integrin, β2 integrin
Cell Type
Endothelial cells, Fibroblasts, Hematopoietic stem and progenitors, Leukemia, Mesenchymal Stem Cells, Neurons, Thymocytes
Biology Area
Immunology, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. McKenzie JL, et al. 1981. J. Immunol. 126:843.
2. Avalos AM, et al. 2002. Biol. Res. 35:231.
3. Wetzel A, et al. 2004. J. Immunol. 172:3850.

Gene ID
7070 View all products for this Gene ID
View information about CD90 on

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 3    Revision Date: 08.04.2014

For Research Use Only. Not for diagnostic or therapeutic use.


This product is supplied subject to the terms and conditions, including the limited license, located at ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.


BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.


8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.


Login / Register
Remember me
Forgot your password? Reset password?
Create an Account